Dalteparin dosage forms and strengths

Revision as of 15:19, 2 February 2014 by ShiSheng (talk | contribs)
Jump to navigation Jump to search
Dalteparin
FRAGMIN® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Forms and Strengths

2,500 IU / 0.2 mL single-dose prefilled syringe 5,000 IU / 0.2 mL single-dose prefilled syringe 7,500 IU / 0.3 mL single-dose prefilled syringe 10,000 IU / 0.4 mL single-dose prefilled syringe 10,000 IU / 1 mL single-dose graduated syringe 12,500 IU / 0.5 mL single-dose prefilled syringe 15,000 IU / 0.6 mL single-dose prefilled syringe 18,000 IU / 0.72 mL single-dose prefilled syringe 95,000 IU / 3.8 mL multiple-dose vial 95,000 IU / 9.5 mL multiple-dose vial[1]


References

  1. "FRAGMIN (DALTEPARIN SODIUM) INJECTION [EISAI INC.]". Retrieved 2 February 2014.

Template:WikiDoc Sources